ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 101 filers reported holding ALX ONCOLOGY HLDGS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,020 | -25.7% | 212,500 | +16.2% | 0.00% | 0.0% |
| Q2 2023 | $1,373 | +139.6% | 182,800 | +44.1% | 0.00% | +100.0% |
| Q1 2023 | $573 | -46.9% | 126,819 | +32.4% | 0.00% | 0.0% |
| Q4 2022 | $1,080 | -99.9% | 95,800 | -43.8% | 0.00% | -50.0% |
| Q3 2022 | $1,633,000 | -11.3% | 170,600 | -25.1% | 0.00% | 0.0% |
| Q2 2022 | $1,842,000 | -26.8% | 227,683 | +53.0% | 0.00% | -33.3% |
| Q1 2022 | $2,515,000 | -30.3% | 148,800 | -11.4% | 0.00% | -25.0% |
| Q4 2021 | $3,608,000 | – | 167,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $163,929,000 | 36.34% |
| Logos Global Management LP | 3,011,352 | $50,892,000 | 6.60% |
| Vivo Capital, LLC | 4,220,048 | $71,319,000 | 4.91% |
| Samsara BioCapital, LLC | 262,786 | $4,441,000 | 1.12% |
| Cormorant Asset Management, LP | 712,079 | $12,034,000 | 0.92% |
| Pier Capital, LLC | 394,443 | $6,666,000 | 0.85% |
| Redmile Group, LLC | 772,397 | $13,054,000 | 0.41% |
| Artal Group S.A. | 500,000 | $8,450,000 | 0.35% |
| Nan Fung Group Holdings Ltd | 41,950 | $709,000 | 0.34% |
| Orbimed Advisors | 621,700 | $10,507,000 | 0.17% |